The first quarter of 2020 saw venture capital funding for telemedicine companies surging to $788 million—a jump of 258% over last year.
As the science on COVID-19 evolves and outbreaks continue throughout the country, businesses are considering implementing or modifying testing programs designed to keep their employees and customers safe.
In March, the federal Office of the National Coordinator for Health Information Technology (ONC) issued a final rule implementing the information blocking prohibition in the 21st Century Cures Act.
According to a recent Pew Study, 68% of voters say healthcare will play an important role in determining which candidate they choose—and 62% say the coronavirus pandemic will be a key factor in driving their decision in November.
Prior to the COVID-19 pandemic, states already were in the midst of a multiyear campaign to combat the opioid epidemic and, increasingly, the broader substance use disorder (SUD) crisis that afflicts millions of Americans.
On March 20, 2020, the Federal Communications Commission (FCC) issued a Declaratory Ruling that exempted certain calls and texts related to COVID-19 from Telephone Consumer Protection Act (TCPA) requirements.
On July 24, President Trump signed four executive orders (EOs) designed to lower drug prices, adding new fuel to the already raging debate around prescription drug costs.
Social determinants of health (SDOH)—the conditions under which people live, learn, work and age—have a greater impact on health risks and outcomes than medical care.
The COVID-19 pandemic is wreaking serious health and economic consequences on children and families.